10:@0.491762:0.959891:0.508561:0.959891:0.508561:0.943626:0.491762:0.943626:0.008399:0.008399
百靈佳殷格翰:@0.449603:0.047478:0.550396:0.047478:0.550396:0.035100:0.449603:0.035100:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799
!:@0.371518:0.187029:0.421915:0.187029:0.421915:0.112760:0.371518:0.112760:0.050397
!:@0.050793:0.261298:0.101190:0.261298:0.101190:0.187029:0.050793:0.187029:0.050397
!:@0.733120:0.813274:0.744880:0.813274:0.744880:0.795944:0.733120:0.795944:0.011759
!:@0.860661:0.840498:0.872420:0.840498:0.872420:0.823169:0.860661:0.823169:0.011759
!:@0.808756:0.867723:0.820515:0.867723:0.820515:0.850393:0.808756:0.850393:0.011759
!:@0.829617:0.894947:0.841376:0.894947:0.841376:0.877618:0.829617:0.877618:0.011759
研發新藥疫苗需要創新的力量──以及有實力的科學合作:@0.070714:0.814566:0.927594:0.814566:0.927594:0.789809:0.070714:0.789809:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.034303:0.033598
夥伴：百靈佳殷格翰的新研究策略為什麼支持開放式創新、:@0.070714:0.851700:0.936256:0.851700:0.936256:0.826944:0.070714:0.826944:0.033598:0.029596:0.029596:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598
與外部專家的交流如何激發研究、以及開放的做法對聘請:@0.070714:0.888835:0.927661:0.888835:0.927661:0.864078:0.070714:0.864078:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.033598:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.034337:0.033598
外部傑出科學家所代表的意義。:@0.070714:0.925969:0.541084:0.925969:0.541084:0.901213:0.070714:0.901213:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598:0.033598
廣納意見:@0.071429:0.183938:0.441005:0.183938:0.441005:0.115858:0.071429:0.115858:0.092394:0.092394:0.092394:0.092394